Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Austria Croatia Czechia France Germany Hungary +6
  • Study on the Effects of Povetacicept for Adults with IgA Nephropathy

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Croatia Czechia Denmark Estonia +13
  • Study on Balstilimab for Patients with Advanced Non-Melanoma Skin Cancers

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study of empagliflozin to improve exercise capacity in patients with hypertrophic cardiomyopathy

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study on Ublituximab for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Croatia Poland
  • Study of Atezolizumab treatment in patients with metastatic bladder cancer (urothelial cancer) after radical cystectomy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +10
  • Study of RO7790121 Treatment for Adults with Moderate to Severe Ulcerative Colitis: Testing Effectiveness and Safety in Initial and Long-term Therapy

    Not recruiting

    3 1
    Investigated Diseases:
    Austria Belgium Bulgaria Croatia Czechia Denmark +10
  • Study of Tiragolumab and Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Germany Greece Hungary Italy The Netherlands +2